Dayton Misfeldt, Director, 10% Owner at SUNESIS PHARMACEUTICALS INC (SNSS), sold 743,700 shares at $6.62 ($4.9M) on 2014-08-08, disclosed to the SEC on 2014-08-12.
Open-market sale of $4.9M SNSS by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.62 | 12,622 | $84K | 1.7% |
| 2 | $6.62 | 662,378 | $4.4M | 88.8% |
| 3 | $6.90 | 591 | $4K | 0.1% |
| 4 | $6.90 | 31,009 | $214K | 4.3% |
| 5 | $6.77 | 694 | $5K | 0.1% |
| 6 | $6.77 | 36,406 |
| $246K |
| 5.0% |
| Total | $6.64 avg | 743,700 | $4.9M | 100% |
| Filing → |
| SNSS | SELL | 2015-12-21 | $2.2M | — | Filing → |
| SNSS | SELL | 2014-08-29 | $2.4M | — | Filing → |
| SNSS | BUY | 2010-07-01 | $6.7M | — | Filing → |